Investment Type: Venture Capital
Mentions in press and media 5
| Date | Title | Description |
| 18.10.2022 | Oculis to go public via SPAC | |
| 29.11.2021 | Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market | SHANGHAI and SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies... |
| 29.11.2021 | Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market | SHANGHAI and SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies... |
| 25.05.2018 | Pivotal bioVenture Partners debuts $150M China-focused biotech fund | The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised a $150 million venture fund to help early-stage life science companies located within China. Sponsored by Agilent Technologies How would you like to win free b... |
| 25.05.2018 | Pivotal bioVenture Partners debuts $150M China-focused biotech fund | The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised a $150 million venture fund to help early-stage life science companies located within China. The new fund will focus on in-licensing products and technologies ... |